Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea · Delayed Price · Currency is KRW 8,960.00
-90.00 (-0.99%)
Oct 23, 2026, 3:30 PM KST
KRX:271980 Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 543,495 | 567,244 | 704,542 | 726,394 | 722,230 | 700,693 |
Revenue Growth | -17.85% | -19.49% | -3.01% | 0.58% | 3.07% | 1.35% |
Gross Profit Gross Profit Growth | 220,028 | 212,904 | 177,495 | 184,256 | 156,798 | 155,571 |
Operating Income Operating Income Growth | 4,079 | 20,995 | -18,550 | 8,888 | -13,332 | -10,380 |
Net Income Net Income Growth | 9,317 | 23,384 | -29,968 | 5,005 | -13,091 | -12,473 |
Earnings Per Share EPS Growth | 637.21 | 1604.77 | -2056.60 | 343.46 | -898.19 | -853.81 |
EPS Growth | 79.86% | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Business Division Pharmaceutical Business Division Growth | 627,995 | 615,599 | 704,211 | 705,338 | 722,230 | 700,693 |
Research & Developent Division Research & Developent Division Growth | 9,843 | 9,078 | 9,006 | 21,056 | - | - |
Important Adjustments Important Adjustments Growth | -94,343 | -57,432 | -8,675 | - | - | - |
Total Total Growth | 543,495 | 567,244 | 704,542 | 726,394 | 722,230 | 700,693 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 67,407 | 58,832 | 57,455 | 35,658 | 31,589 | 28,003 |
Total Debt Total Debt Growth | 112,277 | 93,416 | 75,695 | 71,170 | 54,350 | 47,800 |
Net Cash (Debt) Net Cash Growth | -44,870 | -34,585 | -18,240 | -35,513 | -22,761 | -19,797 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3069.65 | -2373.44 | -1251.75 | -2437.13 | -1561.68 | -1355.11 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3,075 | -5,690 | 3,213 | -4,981 | -15,147 | 19,100 |
Capital Expenditures CapEx Growth | -12,741 | -8,032 | -4,278 | -6,097 | -11,085 | -5,344 |
Free Cash Flow Free Cash Flow Growth | -15,816 | -13,722 | -1,065 | -11,077 | -26,232 | 13,756 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 40.48% | 37.53% | 25.19% | 25.37% | 21.71% | 22.20% |
Operating Margin | 0.75% | 3.70% | -2.63% | 1.22% | -1.85% | -1.48% |
Pretax Margin | 3.44% | 6.16% | -3.83% | 0.26% | -1.83% | -1.97% |
Profit Margin | 1.71% | 4.12% | -4.25% | 0.69% | -1.81% | -1.78% |
FCF Margin | -2.91% | -2.42% | -0.15% | -1.52% | -3.63% | 1.96% |
Fiscal Year | FY 2023 | FY 2022 |
|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 50.000 | 50.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.29% | 0.24% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.06 | 9.44 | - | 49.79 | - | - |
P/FCF Ratio | - | - | - | - | - | 35.94 |
PS Ratio | 0.24 | 0.39 | 0.24 | 0.34 | 0.42 | 0.71 |